Cyclopharm Limited
CYC
Rank in Stocks
#23830
Cyclopharm Limited is an international enterprise specializing in the... Cyclopharm Limited is an international enterprise specializing in the production and global distribution of medical devices and radiopharmaceuticals, with operations spanning Asia Pacific, Europe, Canada, and other regions. The company's business activities are structured into two principal divisions: Technegas and Molecular Imaging. Through its Technegas segment, Cyclopharm supplies diagnostic apparatus and accompanying consumables critical for clinicians in the identification of pulmonary embolisms, alongside distributing third-party offerings to the broader diagnostic imaging sector. Conversely, the Molecular Imaging division provides advanced radiopharmaceutical agents essential for medical practitioners diagnosing conditions such as cancer, various neurological disorders, and cardiac diseases. Cyclopharm primarily serves nuclear medicine departments. Established in 1986, the company's corporate headquarters are located in Kingsgrove, Australia.
Share Price
$0.3148287
Last synced: 2026-11-12
Market Cap
$37.76M
Change (1 day)
-0.35%
Change (1 year)
-24.09%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Cyclopharm Limited (CYC)
Category
Healthcare
EPS for Cyclopharm Limited (CYC)
EPS as of June 2026 TTM: $-0.11
According to Cyclopharm Limited's latest financial reports, its current EPS (TTM) is $-0.11. At the end of 2025 the company had an EPS of $-0.11, a decrease compared to its 2024 EPS of $-0.08.
EPS history for Cyclopharm Limited from 2006 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.11 | -1.55% |
| 2025 | $-0.11 | 32.05% |
| 2024 | $-0.08 | 134.20% |
| 2023 | $-0.03 | -29.30% |
| 2022 | $-0.05 | 19.32% |
| 2021 | $-0.04 | -32.73% |
| 2020 | $-0.06 | 102.67% |
| 2019 | $-0.03 | 7,400.00% |
| 2018 | 0.00 | -97.73% |
| 2017 | $-0.02 | -258.56% |
| 2016 | $0.01 | -82.13% |
| 2015 | $0.06 | 9.14% |
| 2014 | $0.06 | -578.15% |
| 2013 | $-0.01 | -49.15% |
| 2012 | $-0.02 | -15.52% |
| 2011 | $-0.03 | -325.20% |
| 2010 | $0.01 | -75.50% |
| 2009 | $0.05 | 24.88% |
| 2008 | $0.04 | 18.58% |
| 2007 | $0.03 | -50.44% |
| 2006 | $0.07 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $2.70 | -2,593.07% |
US
|
|
| $4.09 | -3,876.55% |
IE
|
|
| $9.45 | -8,825.76% |
US
|
|
| $2.37 | -2,288.37% |
US
|
|
| $1.77 | -1,734.35% |
US
|
Questions about Cyclopharm Limited's earnings per share (EPS)
What is Cyclopharm Limited's earnings per share (EPS)?
Cyclopharm Limited's earnings per share (EPS) over the last twelve months is $-0.11, as of Jun 2026.
What was Cyclopharm Limited's earnings per share (EPS) in 2025?
In 2025, Cyclopharm Limited's earnings per share (EPS) was $-0.11, compared with $-0.08 in 2024.
How has Cyclopharm Limited's earnings per share (EPS) changed since 2020?
From 2020 to 2025, Cyclopharm Limited's earnings per share (EPS) was highest in 2023 ($-0.03) and lowest in 2025 ($-0.11).
How does Cyclopharm Limited's earnings per share (EPS) compare with similar companies?
Cyclopharm Limited's earnings per share (EPS) ($-0.11) is lower than that of all 5 similar companies listed above. The highest among them is Stryker Corporation, with $9.45.